Small Intestine Cancer

What is Small Intestine Cancer?

Small intestine cancer is rare, accounting for approximately 3% of all gastrointestinal malignancies.

Although rare, the small intestine tumour incidence is increasing with a slight male predominance. The median age at diagnosis is the 6th decade. The most frequent primary location is the duodenum. There is no clearly identified environmental risk factor, but adenocarcinomas of the small intestine are associated in almost 20% of cases with predisposing diseases (Crohn’s disease, Lynch syndrome, familial adenomatous polyposis, Peutz–Jeghers syndrome and celiac disease).

Although the small bowel represents 75% of the length of the digestive tract and 90% of its mucosal surface, cancers of the small bowel remain rare and represent around 3% of digestive cancers.
Four main histologic types are present in the small bowel: adenocarcinomas, neuroendocrine tumours, stromal tumours and lymphomas (Lamprecht & Fich, 2016).

Small Intestine

Literature
1. Lamprecht, S., & Fich, A. (2016). Small Intestinal Cancer: Why the Rarity?. Trends in cancer, 2(8), 395–397. https://doi.org/10.1016/j.trecan.2016.06.006

In order to facilitate the use of our website, we use cookies.

Please confirm if you accept our tracking cookies. When declining the cookies, you can continue visiting the website without sending data to third party services. Read our complete cookie statement here.